Dermatitis
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.4 | Q2 | 75.8% | 0.673 | Q2 | 71.6% |
| 2024 | 3.2 | Q1 | 78.1% | 0.888 | Q1 | 81.0% |
| 2023 | 4.0 | Q1 | 85.9% | 0.691 | Q2 | 75.3% |
| 2022 | 5.2 | Q1 | 89.9% | 0.874 | Q1 | 83.0% |
| 2021 | 4.9 | Q1 | 83.8% | 1.503 | Q1 | 93.2% |
| 2020 | — | — | 0.772 | Q1 | 78.9% | |
| 2019 | — | — | 1.351 | Q1 | 91.1% | |
| 2018 | — | — | 0.772 | Q2 | 77.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2162-5220
ISSN
1710-3568
region
Northern America
coverage
2001, 2004-2026